A study about the impact of intensive instruction on the use of Aricept and the reasons for discontinuation in patients with Alzheimer's Disease

Trial Profile

A study about the impact of intensive instruction on the use of Aricept and the reasons for discontinuation in patients with Alzheimer's Disease

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 28 Feb 2017

At a glance

  • Drugs Donepezil (Primary)
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Jul 2016 Planned End Date changed from 31 Mar 2016 to 30 Sep 2017.
    • 24 Dec 2014 Planned End Date changed from 30 Sep 2015 to 31 Mar 2016 as reported by University Hospital Medical Information Network - Japan.
    • 18 Mar 2014 Planned End Date changed to 30 Sep 2015 as reported by University Hospital Medical Information Network - Japan
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top